Monday – May 20, 2019
Hilton San Diego Gaslamp Quarter - Pacific Meeting Room - 401 K Street, San Diego, CA 92101
Contact Jennifer K. Zimmons, Ph.D.
Join as Innovate's management and scientific teams host an Analyst meeting discussing the company's recent updates in NASH and celiac disease.
Innovate Biopharmaceuticals is a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases. Innovate’s lead drug candidate, larazotide acetate, has a mechanism of action that renormalizes the dysfunctional intestinal barrier by decreasing intestinal permeability and reducing antigen trafficking, such as gliadin fragments in celiac disease, and bacterial toxins and immunogenic antigens in nonalcoholic steatohepatitis (NASH). In several diseases, including celiac disease, NASH, Crohn’s disease, ulcerative colitis, irritable bowel syndrome (IBS), type 1 diabetes mellitus (T1DM), chronic kidney disease (CKD), the intestinal barrier is dysfunctional with increased permeability.
Directions from San Diego Convention Center:
San Diego Convention Center to Hilton San Diego Gaslamp Quarter
401 K Street, San Diego, CA 92101